96 related articles for article (PubMed ID: 1994549)
21. The role of leucyl-leucine methyl ester-sensitive cytotoxic cells in skin allograft rejection.
Thiele DL; Geissler GH; Williams FH; Lipsky PE
Transplantation; 1992 Jun; 53(6):1334-40. PubMed ID: 1604489
[TBL] [Abstract][Full Text] [Related]
22. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
23. The action of leucyl-leucine methyl ester on cytotoxic lymphocytes requires uptake by a novel dipeptide-specific facilitated transport system and dipeptidyl peptidase I-mediated conversion to membranolytic products.
Thiele DL; Lipsky PE
J Exp Med; 1990 Jul; 172(1):183-94. PubMed ID: 1972727
[TBL] [Abstract][Full Text] [Related]
24. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.
Filicko-O'Hara J; Grosso D; Flomenberg PR; Friedman TM; Brunner J; Drobyski W; Ferber A; Kakhniashvili I; Keever-Taylor C; Mookerjee B; Talano JA; Wagner JI; Korngold R; Flomenberg N
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1609-19. PubMed ID: 19744572
[TBL] [Abstract][Full Text] [Related]
25. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition.
Li Q; Nagahara N; Takahashi H; Takeda K; Okumura K; Minami M
Toxicology; 2002 Apr; 172(3):181-90. PubMed ID: 11893417
[TBL] [Abstract][Full Text] [Related]
26. T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions.
Friedman TM; Filicko-O'Hara J; Mookerjee B; Wagner JL; Grosso DA; Flomenberg N; Korngold R
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1439-47. PubMed ID: 18022573
[TBL] [Abstract][Full Text] [Related]
27. rIL-4 differentially regulates rIL-2-induced murine NK and LAK killing in CD8+ and CD8- precursor cell subsets.
Merrow MW; Huber BT
Int Immunol; 1991 Jun; 3(6):551-61. PubMed ID: 1909562
[TBL] [Abstract][Full Text] [Related]
28. Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.
Gomez GG; Kruse CA
J Immunother; 2007 Apr; 30(3):261-73. PubMed ID: 17414317
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells.
Thiele DL; Lipsky PE
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):83-7. PubMed ID: 2296607
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-induced transformation of human B lymphocytes: the effect of L-leucyl-L-leucine methyl ester on inhibitory T cell populations.
Ohlin M; Kristensson K; Carlsson R; Borrebaeck CA
Immunol Lett; 1992 Dec; 34(3):221-8. PubMed ID: 1362566
[TBL] [Abstract][Full Text] [Related]
31. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
32. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
[TBL] [Abstract][Full Text] [Related]
33. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
[TBL] [Abstract][Full Text] [Related]
34. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
Lynch DH; Miller RE
J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
[TBL] [Abstract][Full Text] [Related]
35. Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide.
Ballas ZK
J Immunol; 1986 Oct; 137(7):2380-4. PubMed ID: 3489763
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
Alderson MR; Sassenfeld HM; Widmer MB
J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
[TBL] [Abstract][Full Text] [Related]
37. L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment.
Raff RF; Severns E; Storb R; Martin P; Graham T; Sandmaier B; Schuening F; Sale G; Appelbaum FR
Transplantation; 1988 Nov; 46(5):655-60. PubMed ID: 3057686
[TBL] [Abstract][Full Text] [Related]
38. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
39. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
40. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
